Chris Whitmore

Christopher joined Notable Labs as Chief Financial Officer in 2021. Hehasnearly20 years of experience in strategic finance, accounting, operations, investor relations, organizational planning, and oversight. Prior to Notable Labs, he served as Vice President, Finance and Administration for Harpoon Therapeutics, a publicly-traded oncology company. During his tenure, he supported the company’s crossover financing, IPO and public company operations. Prior to Harpoon, he held management positions at Immune Design, AcelRx Pharmaceuticals and Sangamo Therapeutics. He started his career at KPMG LLP, where he served as a manager in the audit practice. Christopher received his B.A. in Business Economics from the University of California, Santa Barbara and holds an active CPA license.